ロード中...
Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines
In vivo dendritic-cell targeting constitutes a promising strategy for anticancer vaccination. Here, we discuss the usage of multivalent DC-SIGN-targeting glycan platforms that allow for the efficient routing of antigens to the endo-lysosomal pathway as well as to a yet uncharacterized cross-presenta...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Landes Bioscience
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3601176/ https://ncbi.nlm.nih.gov/pubmed/23525136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.23040 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|